Liver transplantation in the Nordic countries-An intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 6, 2015, Pages 797-808

  Fosby, Bjarte ^a   Melum, Espen ^b   Bjoro, Kristian ^b,c   Bennet, William ^d   Rasmussen, Allan ^e   Andersen, Ina Marie ^b   Castedal, Maria ^d   Olausson, Michael ^d   Wibeck, Christina ^d   Gotlieb, Mette ^e   Gjertsen, Henrik ^f   Toivonen, Leena ^g   Foss, Stein ^a   Makisalo, Heikki ^g   Nordin, Arno ^g   Sanengen, Truls ^b   Bergquist, Annika ^f   Larsson, Marie E ^h   Soderdahl, Gunnar ^h   Nowak, Greg ⁱ   Boberg, Kirsten Muri ^b   Isoniemi, Helena ^g   Keiding, Susanne ⁱ   Foss, Aksel ^a   Line, Pål Dag ^a   Friman, Styrbjörn ^d   Schrumpf, Erik ^b   Ericzon, Bo Göran ⁱ   Höckerstedt, Krister ^g   Karlsen, Tom H ^b,c   more..

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

End stage liver disease; Indication; Liver transplantation; Organ allocation; Outcome; Registry

Indexed keywords

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ARTICLE; BILE DUCT ATRESIA; BILE DUCT CARCINOMA; BLOOD GROUP A; BLOOD GROUP B; BLOOD GROUP O; BUDD CHIARI SYNDROME; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DENMARK; FEMALE; FINLAND; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER METASTASIS; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NORWAY; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REGISTER; RETRANSPLANTATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; SWEDEN; TIME; TREATMENT OUTCOME; CLINICAL TRIAL; EPIDEMIOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; REOPERATION; SCANDINAVIA; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION; TRENDS;

ADULT; AGED; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; SCANDINAVIAN AND NORDIC COUNTRIES; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84929167253     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2015.1036359     Document Type: Article

References (47)

1. National Institutes of Health Consensus Development Conference: liver transplantation. R I Med J 1984;67:73-6.
2. Klein KB, Stafinski TD, Menon D. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature. PLoS ONE 2013;8:e80661.
3. Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608.
4. Adam R, Karam V, Delvart V, O'Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012;57:675-88.
5. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99-103.
6. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol 1994;21:787-91.
7. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De MC, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994;20:1442-9.
8. van der Poel CL, Ebeling F. Hepatitis C virus: epidemiology, transmission and prevention. Curr Stud Hematol Blood Transfus 1998;62:208-36.
9. Christenson B, Bottiger M, Grillner L. The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect 1997;119:221-5.
10. Bismuth H, Castaing D, Ericzon BG, Otte JB, Rolles K, Ringe B, et al. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet 1987;2:674-6.
11. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a diseasespecific analysis of the UNOS database. Liver Transpl 2004;10:886-97.
12. Levy MF, Somasundar PS, Jennings LW, Jung GJ, Molmenti EP, Fasola CG, et al. The elderly liver transplant recipient: a call for caution. Ann Surg 2001;233:107-13.
13. Pagano D, Grosso G, Vizzini G, Spada M, Cintorino D, Malaguarnera M, et al. Recipient-donor age matching in liver transplantation: a single-center experience. Transplant Proc 2013;45:2700-6.
14. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006;12:1049-61.
15. McElroy LM, Daud A, Davis AE, Lapin B, Baker T, Abecassis MM, et al. A meta-analysis of complications following deceased donor liver transplant. Am J Surg 2014;208:605-18.
16. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:635-47.
17. Bjoro K, Brandsaeter B, Foss A, Schrumpf E. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006;26:69-79.
18. Bjoro K, Friman S, Hockerstedt K, Kirkegaard P, Keiding S, Schrumpf E, et al. Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 1999;34:714-22.
19. Melum E, Schrumpf E, Bjoro K. Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation. Scand J Gastroenterol 2006;41:592-6.
20. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.
21. Cholongitas E, Burroughs AK. The evolution in the prioritization for liver transplantation. Ann Gastroenterol 2012;25:6-13.
22. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
23. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-808.
24. Grunnet N, Bodvarsson M, Jakobsen A, Kyllonen L, Olausson M, Pfeffer P, et al. Scandiatransplant report. 2009; Transplant Proc 2010;42:4429-31.
25. Aune S, Schistad G, Skulberg A. Human liver transplantation without azathioprine. Surg Gynecol Obstet 1972;135:727-8.
26. Aune S. Orthotopic liver transplantation. Ann Chir Gynaecol Fenn 1973;62:175-7.
27. Abouna GM. Organ shortage crisis: problems and possible solutions. Transplant Proc 2008;40:34-8.
28. Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007;39:3169-74.
29. Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi Z. The outcomes of adult liver transplants in the united states from 1987 to 2013. Liver Int 2015. [Epub ahead of print].
30. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000;232:490-500.
31. Aberg F, Gissler M, Karlsen TH, Ericzon BG, Foss A, Rasmussen A, et al. Differences in long-term mortality among liver transplant recipients and the general population: A population-based Nordic study. Hepatology 2015;61:668-77.
32. Petersen C, Harder D, Abola Z, Alberti D, Becker T, Chardot C, et al. European biliary atresia registries: summary of a symposium. Eur J Pediatr Surg 2008;18:111-16.
33. Kumagi T, Drenth JP, Guttman O, Ng V, Lilly L, Therapondos G, et al. Biliary atresia and survival into adulthood without transplantation: a collaborative multicentre clinic review. Liver Int 2012;32:510-18.
34. Boberg KM, Lind GE. Primary sclerosing cholangitis and malignancy. Best Pract Res Clin Gastroenterol 2011;25:753-64.
35. Bjornsson E, Olsson J, Rydell A, Fredriksson K, Eriksson C, Sjoberg C, et al. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism. Scand J Gastroenterol 2005;40:206-16.
36. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011;31:30-60.
37. Rimseliene G, Nilsen O, Klovstad H, Blystad H, Aavitsland P. Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis 2011;11:153.
38. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol 2003; 38:864-70.
39. Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000;35:861-5.
40. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The Epidemiology of Cirrhosis in the United States: A Population-based Study. J Clin Gastroenterol 2014; Epub ahead of print.
41. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011;17:S44-57.
42. Unek T, Karademir S, Arslan NC, Egeli T, Atasoy G, Sagol O, et al. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma. World J Gastroenterol 2011;17:4206-12.
43. Line PD, Karlsen TH, Boberg KM, Schrumpf E, Fosby B, Bentdal Ø, et al. Outcome after liver transplantation for hepatocellular carcinoma (HCC) on extended criteria. Abstract presented at The Scandinavian Transplantation Society XXVI Congress, Reykjavik, Iceland, May 9-12. 2012.
44. Koschny R, Schmidt J, Ganten TM. Beyond Milan criteria-chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin Transplant 2009;23:49-60.
45. Piardi T, Audet M, Odeh M, Panaro F, Cag M, El-ahmar J, et al. Liver transplantation exceeding UCSF criteria: case report of a late recurrence treated by surgery and review of the literature. Eur Surg Res 2010;44:52-5.
46. Friman S, Foss A, Isoniemi H, Olausson M, Hockerstedt K, Yamamoto S, et al. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Scand J Gastroenterol 2011;46:370-5.
47. Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013;257:800-6.